Anzeige
Mehr »
Mittwoch, 03.09.2025 - Börsentäglich über 12.000 News
Geheime Uran-Aktie: Ist das der historische "New Deal"-Moment für amerikanischen Uransektor?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Edison Investment Research

ZeitAktuelle NachrichtenRatingLeser
09.06.Electro Optic Systems - Positioned for drone defence461Electro Optic Systems (EOS) is a specialist defence business focused on remote weapons systems (RWS) and counter drone systems. The group is set to benefit from increased defence spend globally along...
► Artikel lesen
09.06.discoverIE Group - Raising medium-term margin target again606discoverIE's FY25 results highlighted its ability to grow profits and earnings despite pressure on revenue. The adjusted operating margin increased 1.2pp to 14.3%, well ahead of the original 13.5% target...
► Artikel lesen
09.06.Altron - Platform businesses drive FY25 upside608Altron reported EBITDA and operating profit before capital items and headline EPS well ahead of our forecasts for FY25. In the Platforms division, the strength of the FinTech and HealthTech businesses...
► Artikel lesen
06.06.Finsbury Growth & Income Trust - Looking to 'digital winners' for outperformance381Finsbury Growth & Income Trust (FGT) is managed by Nick Train and Madeline Wright at Lindsell Train. They are disappointed by the trust's performance but have a high degree of confidence in FGT's concentrated...
► Artikel lesen
06.06.Immix Biopharma - ASCO/KOL event reaffirms NXC-201's potential393Following Immix's update at the 61st annual American Society of Clinical Oncology conference (ASCO 2025), the company hosted a key opinion leader (KOL) event, which showcased the potential of NXC-201...
► Artikel lesen
05.06.OSE Immunotherapeutics - New UC biomarker underpins growth strategy395OSE has announced plans to strengthen its growth strategy and accelerate the key pillars of its pipeline, covering immuno-inflammation and immuno-oncology. In the inflammation space, the company revealed...
► Artikel lesen
04.06.Braemar - Revised 2030 strategy for growth300Braemar has successfully grown underlying group revenue by c 10% per year since 2013 and the new growth strategy outlines initiatives and targets that are designed to continue top-line growth and improve...
► Artikel lesen
04.06.Franklin Global Trust - An exciting new chapter in the trust's life434Franklin Global Trust (FRGT) was formerly the Martin Currie Global Portfolio Trust. Since October 2018 it has been managed by Zehrid Osmani, who is head of Franklin Templeton's Edinburgh-based Global...
► Artikel lesen
04.06.Chesterfield Special Cylinders - Green shoots from a refocused business384Following the disposal of its Precision Machined Components (PMC) division, Chesterfield Special Cylinders (CSC) is moving forward as a focused, specialist high-pressure cylinder business, as reflected...
► Artikel lesen
03.06.AFT Pharmaceuticals - Setting the stage for sustained long-term growth434AFT Pharmaceuticals reported FY25 revenues of N Z$208m, posting a strong recovery in H2, with dissipating headwinds and traditional H2 seasonality offsetting the softer H1 performance. H225 revenues...
► Artikel lesen
03.06.Intralot - Strong underlying revenue growth in Q125308Intralot has enjoyed a strong start to the year with c 11% growth, albeit EBITDA was broadly flat as the growth came from its lowest margin businesses. Although there is no explicit financial guidance...
► Artikel lesen
03.06.OSE Immunotherapeutics - ASCO 2025 update showcases Tedopi potential359OSE Immunotherapeutics presented multiple updates at the 61st Annual American Society of Clinical Oncology Conference (ASCO 2025) related to Tedopi, its proprietary off-the-shelf neoepitope-based cancer...
► Artikel lesen
03.06.CI Games - Operational and product inflection point457During 2025 (a year with no major releases), CI Games is refining its business model and in the process is also helping to re-define the soulslike genre. We believe that management's latest player-centric...
► Artikel lesen
03.06.Filtronic - New contract with Leonardo553Filtronic has won a new contract with Leonardo, its lead defence customer, worth £0.8m. The contract is to supply high-performance modules for airborne radar applications and is expected to ship in...
► Artikel lesen
03.06.Sareum Holdings - A decisive step towards Phase II303Sareum Holdings has reported the initiation of toxicology studies required ahead of the Phase II studies for its lead TYK2/JAK1 asset, SDC-1801. We view this as a key milestone in SDC-1801's development...
► Artikel lesen
02.06.Cordel Group - US Class 1 win for capture, analytics and PTC315Cordel Group has announced the signing of a new Class 1 freight railroad operator, marking a significant step forward in the company's US growth strategy and its ambitions in Positive Train Control...
► Artikel lesen
02.06.Mendus - Another encouraging ovarian cancer update284Mendus presented a positive clinical update for its Phase I ALISON trial in ovarian cancer at the 61st Annual American Society of Clinical Oncology conference (ASCO 2025). Importantly, the data demonstrated...
► Artikel lesen
02.06.Innovation Agritech Group - Growing smarter next-generation farming254Innovation Agritech Group (IAG) is a UK firm listed on the JP Jenkins share-matching platform. IAG is a technology provider in the global market for vertical farming using its patented modular aeroponic...
► Artikel lesen
02.06.OPAP - Sports and lottery success in Q125973While OPAP's Q125 results include some favourable one-offs, the highest-ever lottery jackpot and operator-friendly results in sports betting, there is a clear message of growing market share in non-exclusive...
► Artikel lesen
29.05.Global Fashion Group - Refined and redefined925Global Fashion Group (GFG) operates leading fashion and lifestyle platforms that enable brands to reach customers in a mix of developed and developing markets with high growth potential. Management...
► Artikel lesen
29.05.Immix Biopharma - Positive newsflow continues for NEXICART-2420Immix Biopharma has announced a positive clinical update for the US-based Phase I/II NEXICART-2 trial, investigating lead CAR-T candidate NXC-201 as a potential treatment for relapsed/refractory (r/r)...
► Artikel lesen
28.05.Rockwood Strategic - Different approach has favourable outcomes288Rockwood Strategic (RKW) is managed by Richard Staveley at Harwood Capital. He has a differentiated approach, aiming to generate a 15% annual internal rate of return (IRR) over a rolling five-year period...
► Artikel lesen
27.05.Cereno Scientific - Firing on all cylinders456In Q125, Cereno made tangible progress across both its clinical programmes. The period opened with new data for lead asset CS1 indicating disease-modifying signals, and was capped by FDA endorsement...
► Artikel lesen
27.05.Datatec - Strong performance drives increased dividend payout policy516Datatec reported a strong set of results for FY25, with gross profit, adjusted EBITDA and underlying EPS all ahead of our forecasts. All three divisions reported strong growth in adjusted EBITDA, highlighting...
► Artikel lesen
27.05.Alphamin Resources - Honing FY25 forecasts435Notwithstanding press headlines reading 'Alphamin Resources profit slumps in first quarter on DRC disruptions', the company's Q125 results were universally better than in Q124 and consistent with its...
► Artikel lesen